Samsara BioCapital as of March 31, 2020
Portfolio Holdings for Samsara BioCapital
Samsara BioCapital holds 28 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Intercept Pharmaceuticals In | 14.6 | $25M | 404k | 62.96 | |
| Principia Biopharma | 13.7 | $24M | 401k | 59.38 | |
| Springworks Therapeutics (SWTX) | 9.7 | $17M | 625k | 27.00 | |
| Odonate Therapeutics Ord | 8.3 | $14M | 523k | 27.61 | |
| Allakos | 6.9 | $12M | 271k | 44.49 | |
| Sutro Biopharma (STRO) | 6.6 | $12M | 1.1M | 10.20 | |
| Atreca Inc Cl A (BCEL) | 5.7 | $9.9M | 597k | 16.55 | |
| Syros Pharmaceuticals | 5.5 | $9.6M | 1.7M | 5.56 | |
| Liquidia Technologies (LQDA) | 2.7 | $4.8M | 1.0M | 4.71 | |
| Hookipa Pharma Inc equity | 2.5 | $4.4M | 530k | 8.25 | |
| Rhythm Pharmaceuticals (RYTM) | 2.4 | $4.2M | 276k | 15.22 | |
| Millendo Therapeutics | 2.3 | $4.0M | 751k | 5.28 | |
| Bellus Health | 2.3 | $3.9M | 394k | 9.93 | |
| Pieris Pharmaceuticals | 2.1 | $3.7M | 1.6M | 2.28 | |
| Aimmune Therapeutics | 1.9 | $3.4M | 233k | 14.42 | |
| Aravive | 1.9 | $3.3M | 576k | 5.76 | |
| Iveric Bio | 1.7 | $3.0M | 863k | 3.44 | |
| Aclaris Therapeutics (ACRS) | 1.6 | $2.7M | 2.6M | 1.04 | |
| Sunesis Pharmaceuticals Inc Ne | 1.4 | $2.5M | 5.9M | 0.41 | |
| Rocket Pharmaceuticals (RCKT) | 1.0 | $1.8M | 128k | 13.95 | |
| Urovant Sciences | 0.8 | $1.5M | 158k | 9.22 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $1.3M | 168k | 7.65 | |
| Catabasis Pharmaceuticals Ord | 0.7 | $1.2M | 300k | 4.15 | |
| Bluebird Bio | 0.7 | $1.1M | 25k | 45.95 | |
| Portola Pharmaceuticals | 0.7 | $1.1M | 160k | 7.13 | |
| Akero Therapeutics (AKRO) | 0.6 | $1.1M | 50k | 21.20 | |
| Amarin Corporation | 0.4 | $781k | 195k | 4.00 | |
| Kala Pharmaceuticals | 0.3 | $563k | 64k | 8.78 |
